The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical efficacy of STA-12-8666, an HSP90 inhibitor-targeted SN-38 conjugate, in small cell lung cancer (SCLC).
 
Yanis Boumber
Consulting or Advisory Role - Clovis Oncology
Travel, Accommodations, Expenses - Clovis Oncology
 
Anna Gaponova
No Relationships to Disclose
 
Anna S Nikonova
No Relationships to Disclose
 
Alexander Deneka
No Relationships to Disclose
 
Alexander Kudinov
No Relationships to Disclose
 
Brian L. Egleston
Consulting or Advisory Role - Teva
Research Funding - Janssen (Inst); Verilogue (Inst)
 
James S Duncan
Honoraria - Array BioPharma
Travel, Accommodations, Expenses - Array BioPharma; Pfizer
 
Kelly Duncan
No Relationships to Disclose
 
Hossein Borghaei
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Genentech; Lilly
Research Funding - Millennium (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Genentech; Lilly
 
Ranee Mehra
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bayer/Onyx; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - Genentech
 
David A. Proia
Employment - Synta
Stock and Other Ownership Interests - Synta
Patents, Royalties, Other Intellectual Property - Synta
 
Erica Golemis
No Relationships to Disclose